Anti Soluble Liver Antigen (SLA), in Visit Clinic

An anti‑SLA test is a blood test that detects antibodies to the soluble liver antigen (SLA), a specific autoantibody linked to autoimmune hepatitis. Measured by ELISA or immunoblot, it helps confirm autoimmune hepatitis—especially when other autoantibodies are absent—and may signal a more severe disease course. Results are interpreted alongside clinical findings and liver function tests.

An anti‑SLA (soluble liver antigen) test detects autoantibodies associated with autoimmune hepatitis. A positive result is highly specific and supports the diagnosis, often accompanying elevated liver enzymes, raised IgG, and a tendency toward more severe disease. A negative result does not exclude autoimmune hepatitis. Results must be interpreted with clinical findings, other autoantibodies (ANA, SMA), liver function tests, and sometimes liver biopsy.

A SLA test is a blood test that detects antibodies to the soluble liver antigen (SLA/LP), an autoantigen linked to autoimmune hepatitis. Detecting anti‑SLA antibodies supports diagnosis—sometimes when other autoantibodies are absent—and can suggest a more severe or progressive form. Results are interpreted alongside liver function tests, imaging and, if needed, liver biopsy.

The full form of SLA antibody is soluble liver antigen antibody (commonly called anti‑SLA or anti‑SLA/LP). It is a specific serological marker for autoimmune hepatitis and is often associated with a more severe disease course. Anti‑SLA may occur alone or alongside other autoantibodies and is detected by ELISA or immunoblot tests to aid diagnosis and prognosis.

SLA stands for Service Level Agreement. In performance testing, an SLA is a formal contract or commitment defining expected system performance such as availability, response time, throughput, and error rates, plus measurement methods, thresholds, reporting, and remedies for breaches. SLAs set test targets, validate whether applications meet operational requirements, and help ensure agreed user experience and reliability.

Common comorbid conditions associated with asthma include allergic rhinitis (hay fever), atopic dermatitis (eczema), chronic rhinosinusitis with nasal polyps, gastroesophageal reflux disease (GERD), obesity, obstructive sleep apnea, and COPD/asthma overlap. Respiratory infections frequently trigger exacerbations, and anxiety or depression often co‑occur, worsening control. Seek tailored treatment for best control.